$17.65
-0.13-0.73%
At close: Sep 28, 5:00 PM EST
$17.64
-0.01-0.06%
After Hours: 4:00 PM EST

Attovia Therapeutics (ATTO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-4.62 | $-0.17 | $-0.15 | $-0.54 |
| Actual | $-4.88 | $0.10 | $-0.83 | $-4.99 |
| Surprise | -5.63% | +158.8% | -453.3% | -824.1% |
| Revenue | ||||
| Estimate | — | $350.1M | $372.2M | $346.3M |
| Actual | $450000 | $346.8M | $363.8M | $356.6M |
| Surprise | — | -0.94% | -2.26% | +2.98% |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.52 |
| Revenue | |
| Consensus | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Sep 2, 2026 | $-4.88 | $-4.62 | -5.63 % |
| Q3 | Nov 15, 2022 | $0.10 | $-0.17 | 158.8 % |
| Q2 | Aug 3, 2022 | $-0.83 | $-0.15 | -453.3 % |
| Q1 | May 11, 2022 | $-4.99 | $-0.54 | -824.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 15, 2022 | $346.80M | $350.08M | -0.94 % |
| Q2 | Aug 3, 2022 | $363.80M | $372.22M | -2.26 % |
| Q1 | May 11, 2022 | $356.60M | $346.27M | 2.98 % |
| Q4 | Mar 30, 2022 | $327.20M | $368.55M | -11.2 % |